Belite Bio (BLTE) Balance Sheet: Assets & Liabilities

Belite Bio (BLTE) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Belite Bio reported total assets of $780.56M and total liabilities of $10.07M. Shareholders' equity was $770.49M, up 428.4% from $145.82M a year earlier. Total debt stood at $429.00K against $492.42M in cash and short-term investments, a net cash position of $491.99M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Belite Bio Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Belite Bio, Inc (BLTE) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	352.93	31.68	88.16	42.09	42.09	17.34	25.62
Short-Term Investments	139.49	113.47	0.00	0.00	-	0.00	0.00
Cash & Short-Term Investments	492.42	145.15	88.16	42.09	42.09	17.34	25.62
Accounts Receivable	0.72	0.59	0.87	0.02	0.02	0.02	0.04
Inventory	0.00	0.00	0.00	-0.02	-	0.00	0.00
Other Current Assets	1.13	1.33	0.92	0.72	0.72	0.06	0.01
Total Current Assets	494.27	147.07	89.94	42.81	42.81	17.43	25.67
Non-Current Assets
Property, Plant & Equipment (Net)	0.78	0.97	1.30	1.38	1.35	0.09	0.07
Long-Term Investments	280.17	0.00	0.00	0.00	-	0.00	0.00
Intangible Assets	4.92	3.96	3.30	0.03	0.03	0.00	0.00
Other Non-Current Assets	0.43	0.10	0.10	0.06	0.12	0.82	0.01
Total Non-Current Assets	286.28	5.06	4.70	1.47	1.47	0.92	0.07
Total Assets	780.56	152.13	94.64	44.27	44.27	18.35	25.74
Current Liabilities
Accounts Payable	0.00	0.01	0.00	0.00	-	0.07	0.00
Short-Term Debt	0.24	0.28	0.31	0.40	-	0.00	0.00
Accrued Liabilities	9.64	4.77	3.33	-	1.45	1.41	0.97
Other Current Liabilities	9.64	0.29	3.33	1.71	0.07	0.10	0.97
Total Current Liabilities	9.88	6.05	3.63	2.10	2.10	1.64	0.97
Non-Current Liabilities
Long-Term Debt	0.19	0.26	0.58	0.67	0.67	31.81	31.81
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Non-Current Liabilities	0.19	0.26	0.58	0.67	0.67	31.81	31.81
Total Liabilities	10.07	6.31	4.21	2.77	2.77	33.44	32.78
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-185.26	-107.65	-71.50	-39.87	-39.87	-27.22	-17.56
Accumulated Other Comprehensive Income	-0.54	-0.66	-0.37	-0.39	-0.39	-0.20	-0.04
Additional Paid-in Capital	956.28	254.13	162.31	81.76	81.76	12.33	10.56
Shares Outstanding	39.34	31.83	29.15	-	24.90	24.10	-
Total Stockholders' Equity	770.49	145.82	90.43	41.50	41.50	-15.09	-7.04
Total Liabilities & Equity	780.56	152.13	94.64	44.27	44.27	18.35	25.74

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Belite Bio Balance Sheet

How much debt does Belite Bio have?

Belite Bio had total debt of $429.00K as of Dec 31, 2025, against $492.42M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $537.00K a year earlier.

What are Belite Bio's total assets?

Belite Bio reported total assets of $780.56M as of Dec 31, 2025, up 413.1% from $152.13M a year earlier. Total liabilities were $10.07M.

What is Belite Bio's shareholders' equity?

Belite Bio's shareholders' equity was $770.49M as of Dec 31, 2025, or about $19.59 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition